Gainers
Arena Pharmaceuticals, Inc. ARNA rose 10.33 percent to $2.03 in pre-market trading after the company reported favorable results from Phase 1b trial of APD371.
Amicus Therapeutics, Inc. FOLD shares rose 8.70 percent to $8.50 in pre-market trading after dropping 3.58 percent on Monday
LivePerson, Inc. LPSN shares rose 4.66 percent to $6.07 in pre-market trading after gaining 0.35 percent on Monday.
Yandex NV YNDX shares rose 3 percent to $16.15 in pre-market trading. Goldman Sachs upgraded Yandex from Neutral to Buy.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
Juniper Networks, Inc. JNPR shares fell 7.59 percent to $23.00 in pre-market trading as the company lowered its forecast for the first quarter. Juniper expects adjusted Q1 earnings of $0.35 to $0.37 per share on revenue of $1.09 billion to $1.1 billion.
Horizon Pharma PLC HZNP shares fell 5.54 percent to $17.21 in pre-market trading. Horizon Pharma has requested an approval for 16 million buyback. The company expects FY16 revenue of $1.025 billion to $1.05 billion and adjusted EBITDA of $505 million to $520 million.
Fastenal Company FAST shares fell 3.62 percent to $45.24 in pre-market trading. Fastenal reported Q1 earnings of $0.44 per share on revenue of $986.7 million.
Alcoa Inc AA shares fell 3.19 percent to $9.42 in pre-market trading. Alcoa reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates.
Starbucks Corporation SBUX shares fell 2.12 percent to $59.61 in pre-market trading. Deutsche Bank downgraded Starbucks from Buy to Hold.
Spirit Realty Capital, Inc (New) SRC fell 1.44 percent to $11.29 in pre-market trading after the company announced an upsize to a previously announced public offering. Spirit Realty announced the pricing of its underwritten public offering of 30 million shares of its common stock, up from a previously announced 27 million share offering at $11.15 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.